Arizona State Retirement System Akebia Therapeutics, Inc. Transaction History

Arizona State Retirement System

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$0.32 - $0.67 $14,377 - $30,103	-44,930 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$0.72 - $2.93 $218 - $887	303 Added 0.68%	44,930 $32,000
Q4 2021 Feb 04, 2022	BUY	$2.26 - $3.34 $7,218 - $10,667	3,194 Added 7.71%	44,627 $101,000
Q3 2021 Nov 12, 2021	BUY	$2.35 - $3.88 $4,213 - $6,956	1,793 Added 4.52%	41,433 $119,000
Q2 2021 Aug 02, 2021	SELL	$2.83 - $4.2 $939 - $1,394	-332 Reduced 0.83%	39,640 $150,000
Q1 2021 May 06, 2021	BUY	$2.92 - $5.06 $1,422 - $2,464	487 Added 1.23%	39,972 $135,000
Q4 2020 Jan 28, 2021	SELL	$2.22 - $3.78 $2,226 - $3,791	-1,003 Reduced 2.48%	39,485 $111,000
Q3 2020 Nov 05, 2020	BUY	$2.39 - $13.08 $35,811 - $195,990	14,984 Added 58.75%	40,488 $102,000
Q2 2020 Aug 04, 2020	BUY	$6.67 - $13.58 $49,051 - $99,867	7,354 Added 40.52%	25,504 $346,000
Q1 2020 May 05, 2020	BUY	$4.1 - $10.24 $74,415 - $185,856	18,150 New	18,150 $138,000

121

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $325M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.